Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Common Stock, $0.0001 par value
-
Shares outstanding
-
170,107,714
-
Total 13F shares
-
169,807,590
-
Share change
-
-1,712,483
-
Total reported value
-
$3,663,065,967
-
Put/Call ratio
-
41%
-
Price per share
-
$21.57
-
Number of holders
-
308
-
Value change
-
-$28,402,849
-
Number of buys
-
142
-
Number of sells
-
177
Institutional Holders of ACADIA PHARMACEUTICALS INC - Common Stock, $0.0001 par value (ACAD) as of Q2 2025
As of 30 Jun 2025,
ACADIA PHARMACEUTICALS INC - Common Stock, $0.0001 par value (ACAD) was held by
308 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
169,807,590 shares.
The largest 10 holders included
BAKER BROS. ADVISORS LP, BlackRock, Inc., VANGUARD GROUP INC, RTW INVESTMENTS, LP, STATE STREET CORP, MORGAN STANLEY, Point72 Asset Management, L.P., GEODE CAPITAL MANAGEMENT, LLC, CITADEL ADVISORS LLC, and Palo Alto Investors LP.
This page lists
308
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.